Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Zomedica Corp.ZOM · Entity 6884 | Director | March 13, 2020 | March 17, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Zomedica Corp.
Report date March 13, 2020 · Filed March 17, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.19 · Expires 2025-03-13 | Direct | 200,000 |
Reported balance
After 2020-03-13 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-03-13 · Grant · Acquired 200,000 · Balance 200,000 F1: The option vests in 4 equal annual installments commencing March 13, 2020. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests in 4 equal annual installments commencing March 13, 2020.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 13, 2020 Filed Mar 17, 2020 16:12 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantStock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $0.19 | $0.00 |
DisclosureSEC source: 0001171843-20-001788 · ownership.xml · derivative · entry 1 LeBar James · CIK 0001721721 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Shares, without par value · 200,000 shares Expires 2025-03-13 F1 · derivative.exercise_date: The option vests in 4 equal annual installments commencing March 13, 2020. Read SEC document |
| January 10, 2019 Filed Jan 14, 2019 16:15 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantStock Option (right to buy) · Derivative | 400,000 | $0.00 Strike: $1.52 | $0.00 |
DisclosureSEC source: 0001171843-19-000266 · ownership.xml · derivative · entry 1 LeBar James · CIK 0001721721 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Shares, without par value · 400,000 shares Expires 2021-01-10 F1 · derivative.exercise_date: The options vested upon grant. The option is currently fully vested. Read SEC document |
| August 28, 2018 Filed Aug 30, 2018 16:14 UTC | Zomedica Corp. ZOM · Entity 6884 | SaleCommon Shares, without par value | 200,000 | $2.15 | $430,000.00 |
DisclosureSEC source: 0000905718-18-000775 · zomedica_form4aug282018.xml · nonDerivative · entry 1 LeBar James · CIK 0001721721 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Read SEC document |
| January 24, 2018 Filed Mar 27, 2018 16:59 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $0.20 | $0.00 |
DisclosureSEC source: 0000905718-18-000336 · zomedica_form4jan242018.xml · derivative · entry 2 LeBar James · CIK 0001721721 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, without par value · 100,000 shares Expires 2018-04-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options vested upon grant. The option is currently fully vested. Read SEC document |
| January 24, 2018 Filed Mar 27, 2018 16:59 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionCommon Shares, without par value | 100,000 | $0.20 | $20,000.00 |
DisclosureSEC source: 0000905718-18-000336 · zomedica_form4jan242018.xml · nonDerivative · entry 1 LeBar James · CIK 0001721721 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.